Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SPT | PUBM |
|---|---|---|
| Price | $10.73 | $18.62 |
| Change today | ▲ 1.61% | ▲ 0.27% |
| Market cap | $650.15M | $848.14M |
| Return, 3 months | +28.0% | +37.3% |
| Return, year to date | -4.8% | +109.9% |
| Return, 1 year | -8.2% | +109.4% |
| P/E (TTM) | -21.5 | -64.2 |
| P/B | 2.8 | 3.6 |
| P/E percentile vs own 5y | 70th | 6th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +10.8% | +10.5% |
| Net profit growth (YoY) | +74.2% | +76.9% |
| Gross margin | 77.4% | 64.4% |
| Operating margin | -5.9% | -5.0% |
| Net margin | -6.1% | -4.7% |
| Return on equity | -14.3% | -5.6% |
| Analyst target vs. price | -0.2% | +12.8% |
| Analyst buy share | 38% | 90% |
| RSI (14) | 55 | 61 |
| 30-day volatility | 56.4% | 37.6% |
| Max drawdown, 1 year | -64.7% | -42.8% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
